P3 Featured

Seventy-two per cent of pharmacists say their work is having a negative impact on their mental health while nine-tenths are at high risk of burnout.

Boots UK and Alliance Healthcare have donated 500,000 dexamethasone tablets to the NHS to help treat patients hospitalised with Covid-19.

The NPA has urged Rishi Sunak to set aside some of the £3 billion for the NHS to support pharmacies.

In an effort to accelerate the decline in smoking prevalence and smoking-related population harm, the tobacco harm reduction approach has been increasingly recognised by public health organisations. 

Essential agrees to continue to supply lithium drug in UK for at least five years.

CPNI chief Gerard Greene urges the public to show pharmacies patience during the second wave of Covid-19.

The CAC sides with the PDA Union on the proposed bargaining unit, rejecting Lloyds' claim that all store workers should be included. 

Scottish pharmacies have been forced to close by the country’s Test and Protect programme because staff were not wearing appropriate PPE.

DHSC will advise which wholesalers have been allocated stock via the NHSBSA website.

Ninety-five per cent of Kent pharmacies experienced problems with staffing levels during the first wave of the coronavirus pandemic.

The government has extended the visas of thousands more overseas health workers including pharmacists.

LloydsPharmacy parent company McKesson UK is “insisting” on a 25 per cent discount from its health centre landlords.

The autonomous vehicle is the first such vehicle to travel on roads in the UK.

The extensive and under-recognised impact eczema can have on all aspects of people’s lives are revealed in a new report.

The number of community pharmacies in England dropped to its lowest level in five years by the end of March 2020.

The majority of LPCs think their relationship with PSNC has improved over the past year despite the turmoil of Covid-19, according to poll.

New standards include the aim of people being independent prescribers at the point of registration.

New company will rival Teva in global generics market.

Government say Pfizer/BioNTech and Oxford vaccines could be available before year end

A split pre-reg scheme has increased the number of trainees to surgeries this year.